A cyclized peptide for studies of human parvovirus B19 infection.
Synthetic peptides corresponding to human parvovirus B19 sequences were evaluated for immunoreactivity with the sera of infected persons. A cyclized peptide deduced from the N terminus of viral protein VP2 and containing the amino acids 284-307 showed a high reactivity with IgM class antibodies when comparing seropositive and seronegative sera.
Fridell
E
E
Department of Virology, National Bacteriological Laboratory, Stockholm, Sweden.
Trojnar
J
J
Mehlin
H
H
Wahren
B
B
D000914:Antibodies, Viral / Q000032:analysis*; D001483:Base Sequence; D006801:Humans; D007075:Immunoglobulin M / Q000032:analysis; D008969:Molecular Sequence Data; D010321:Parvoviridae / Q000276:immunology; D010322:Parvoviridae Infections / Q000175:diagnosis*; D010456:Peptides, Cyclic / Q000276:immunology*; D014764:Viral Proteins / Q000276:immunology*
D000914:Antibodies, Viral; D007075:Immunoglobulin M; D010456:Peptides, Cyclic; D014764:Viral Proteins